Financial Performance: Revenue, earnings, and profit margins directly influence investor confidence and stock value.

Industry Trends: Overall health and growth prospects of the biotechnology sector impact investor sentiment towards Protagonist Therapeutics.

Clinical Trial Results: Positive data from clinical trials of Protagonist's drug candidates can drive the stock price higher, while negative results can lead to declines.

Regulatory Approvals: FDA approval of Protagonist's drugs is a major catalyst for stock appreciation.

Competition: The competitive landscape, including the presence of rival therapies, affects market share and pricing power.

Market Conditions: Broader economic trends and overall market sentiment can impact the demand for stocks, including PROT.US.

Company News: Announcements regarding partnerships, acquisitions, or other corporate developments can affect investor perceptions.

Analyst Ratings: Recommendations from financial analysts can influence investment decisions and stock price movements.